GenomOncology

Frederick Health sees spike in suggested cancer treatment changes and increase in precision medicine and clinical trial referrals using first-of-its-kind integrations between MEDITECH #Expanse #Genomics and GenomOncology precision oncology platform. ????Watch our video to learn more about Frederick Health's Genomics program: https://hubs.ly/Q038CyTy0 Read our press release to learn about Frederick Health's latest integration with GenomOncology:? https://hubs.ly/Q038B_tB0 Helen Waters Catherine Turner Rachel Wilkes, MBA, CPM Jason Patnode Jennifer Ford, MBA Garry Miller, MSHMI, MBA Rose McCarthy

MEDITECH + GenomOncology direct patient impact: "In the first six months, Frederick Health recorded?96 patients who received a treatment change?based on the advanced recommendations that target the genetics of each patient’s individual cancer.... 56 new referrals to their own clinical trials program?within the first six months.?Previously, the organization only averaged two clinical trial referrals in the six months prior to go-live. Having this information readily accessible to clinicians allows them to seek alternate treatment options, including clinical trials hosted by Frederick Health, which could both prove lifesaving and allow them to continue to treat patients in-house." Full article: https://lnkd.in/gU6mGK-8 More about MEDITECH Genomics: https://lnkd.in/g_g8zrh4 More about GenomOncology: https://lnkd.in/gbT2ZFMV cc: Jennifer Ford, MBA #oncology #genomics #precisiononcology

Enhancing patient care and driving meaningful clinical improvement is what fuels our work here at GenomOncology. Seeing these #clinicaltrial referral results from our collaboration with MEDITECH at Frederick Health will continue to promote our passion for providing data-forward solutions that show results! #CancerInformatics #PatientForwardCare #Oncology #Bioinformatics #CancerGenomics https://lnkd.in/eMFda-2e

Going to HIMSS Global Health Conference & Exhibition? Our Chief Commercial Officer, Garreth Hippe would like to connect. Tell us how you are integrating your multi-omics data. We may have ways to help enable your data to quickly and more efficiently improve patient care in oncology and beyond. Click below to schedule some time. #HIMSS25 #GeneticsReporting #Bioinformation #CancerGenetics #Genomics #MultiomicData #Pathlogy #ClinicalDataEnablement #HealthInformation

We are thrilled to announce our strategic co-marketing partnership with Pillar Biosciences Incorporated! This collaboration merges GenomOncology's advanced clinical decision support platform with Pillar's state-of-the-art NGS testing solutions. Together, we're revolutionizing how oncologists access and interpret genomic data to make precise treatment decisions. Our integrated solution streamlines the path from NGS testing to actionable clinical insights, enabling faster, more informed treatment decisions for cancer patients. This partnership represents a significant step forward in making precision oncology more accessible and efficient for healthcare providers worldwide. #PrecisionOncology #PrecisionMedicine #NGS #CancerGenomics #Oncology #BioinformaticsSolutions #CancerCare #PersonalizedMedicine #DigitalHealth #MolecularDiagnostics #ClinicalGenomics #BiotechNews #HealthTech #CancerResearch #GenomicMedicine

We're excited to share our latest blog post discussing the updated AMP/ASCO/CAP guidelines for somatic variant classification and their impact on precision oncology. Learn how these changes will enhance standardization and improve oncology care through genomics. ???? #PrecisionMedicine #CancerGenomics #Oncology #MolecularDiagnostics #BioinformaticsUpdates #CancerCare #GenomicMedicine #PathologyGuidelines #AMP #ASCO #CAP

?? Transforming Cancer Care: Scott Cesen on GenomOncology's Innovations Bell Falls Search Focus on Talent #Podcast ??? Episode 40 - Part 7 ?? Join the conversation with Scott Cesen as he discusses GenomOncology's mission to empower medical professionals with data-driven insights for better cancer care strategies. ?? Discover the complexities of clinical trials and how GenomOncology navigates these challenges to make life-saving treatments more accessible. Gretchen Kemp Ian Maurer Audric Wertz Michael C. James Cole Paul Franke Tracey (Zimmerman) Cesen Ed Kalaher Pat Duncan Chris Duncan

Explore the intersection of AI and oncology data with GenomOncology's CTO Ian Mauer and Cleveland Clinic's Dr. Jasmin Hundal. Listen as they discuss how AI is changing the face of precision oncology, including turning unstructured data from places like EHR records into actionable clinical information. They explain how AI and human decision making can work hand-in-hand to bridge the gaps in oncology care. Discover more about GenomOncology's data enablement solutions: www.genomoncology.com. #precisiononcology #AIHealthcare #MachineLearningOncology #OncologyInformatics #PatientCenteredCare

Missed GenomOncology at the Association for Molecular Pathology (AMP) Conference? Don’t miss this! Discover how Dr. 'Craig' Alexander Mackinnon at the University of Alabama at Birmingham is transforming patient care through cutting-edge genomic data integration using GenomOncology solutions. Watch the video now:?https://lnkd.in/g9YDbb5Q #healthcaredata #genomics #cancergenetics #clinicalanalytics #dataintegration

We are excited to announce the appointment of Dr. 'Jack' Jonathan Lord M.D. to the Board of Directors at GenomOncology! Dr. Lord brings a wealth of expertise in oncology, genomics, and healthcare innovation, making him a valuable addition to our team. His leadership and vision will help us further our mission to transform precision medicine through data-driven solutions. We look forward to the invaluable insights he will bring as we continue to advance our initiatives in precision oncology and precision medicine. Welcome aboard, Dr. Lord! Read the full announcement here: https://lnkd.in/dfcapUyx #GenomOncology #Oncology #PrecisionMedicine #Leadership #Innovation